Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH

WESTBOROUGH, Mass., Aug. 18, 2025 /PRNewswire/ -- Echosens, the leader in non-invasive liver diagnostics, and Novo Nordisk are strengthening their aligned efforts to combat steatotic liver disease, following the U.S. Food and Drug Administration's approval of Wegovy® (semaglutide) for the...